By Distribution Channel

GPO-Channeled Supply (U.S.) Market Analysis

Cross-industry research covering GPO-Channeled Supply (U.S.) across 1 market reportspanning Pharmaceuticals & Diagnostics.

1 Reports
1 Industries

Reports Covering GPO-Channeled Supply (U.S.)

Hematology Analyzers and Reagents Market to Reach USD 8.9 Billion by 2033 at 6.4% CAGR

Pharmaceuticals & Diagnostics·Market: USD 5.4 Billion (2025)·CAGR: 6.4%

Premier, Vizient, and HealthTrust GPO contracts consolidate hematology reagent purchasing across member hospitals; GPO leverage is partially offset by OEM sole-source clauses in reagent rental placements.

6%

Market Share

4.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments